---  
layout: startup_page  
title: "Engrail Therapeutics"  
id: "engrail.com"  
permalink: "/engrailtherapeuticsengrail.com03192024/"  
website: "https://engrail.com/"  
funding_round: "Series B"  
funding_amount: "$157M"  
investors: "F-Prime Capital, Forbion, Norwest Venture Partners, RiverVest Venture Partners, Red Tree Venture Capital, funds managed by abrdn Inc., Ysios Capital, Longwood Fund, Eight Roads Ventures, Pivotal Life Sciences"  
about: "Engrail Therapeutics is a clinical-stage pharmaceutical company focused on developing transformative therapies for neuropsychiatric and neurodevelopmental disorders. They are advancing a pipeline of treatments for conditions such as anxiety disorders, depression, and rare neurodegenerative diseases, addressing significant unmet medical needs."  
markets: "Neuroscience, Pharmaceuticals"  
hq: "San Diego, California, United States"  
founded_year: "2019"  
linkedin: "https://www.linkedin.com/company/engrail-therapeutics"  
twitter: "https://twitter.com/engrail_tx"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/engrail-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/328782-43"  

date_display: "19-Mar-2024"  
date: "2024-03-19"

# SEO Optimization  
meta_title: "Engrail Therapeutics - Series B Funding ($157M)"  
meta_description: "Engrail Therapeutics, Engrail Therapeutics is a clinical-stage pharmaceutical company focused on developing transformative therapies for neuropsychiatric and neurodevelopme..."  
meta_keywords: "Engrail Therapeutics, Neuroscience, Pharmaceuticals, Series B funding"  
canonical_url: "https://startup.projectstartups.com/engrailtherapeuticsengrail.com03192024/"  
---